Dave Rosa, CEO of NeuroOne, outlines the company's minimally invasive electrode technology designed to improve neurological care for patients with motor issues and pain, using thin-film, flexible electrodes implanted on the brain.

Dr. Mark Zhang, acting assistant under secretary for health at the U.S. Department of Veterans Affairs, discusses the VA Puget Sound Health Care System's X_Labs and 3D-printed bone grafts.

Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.

Teresa Cope, CEO of Manx Care, outlines the Isle of Man government's 2026 Innovation Challenge, an initiative designed to attract technology solutions that can support the Island's vision for digitally enabled, sustainable healthcare.

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

H.E. Mubaraka Ibrahim, CIO and chief AI officer of Emirates Health Services, says the country is building an AI governance model that pairs clinical innovation with policy, training and prevention-focused population health.